Sentence examples for go biologic from inspiring English sources

The probability of observing a particular number of genes in one GO biologic process (bioprocess) was tested using hypergeometric distribution as previously described (Tavazoie et al. 1999).

Using DAVID, we identified KEGG pathways and GO biologic categories overrepresented among the strict sleep enhanced genes in the lung: carbohydrate metabolism, glycoproteins and sulfur metabolism.

The p-values were calculated using the following formula: In this study, we focused only on the gene annotations of GO biologic process and used Affymetrix nonredundant build of human GO annotations downloaded 18 May 2004.

Upon infusion, they go to work as biologic homing devices, orchestrating a molecular onslaught against the tumor.

Scientists at two companies that currently sell somatropin products, Serono of Geneva and Genentech of California, say that generic biologics need to go through exactly the same testing as the original biologics.

As a trade-off for opening that market to generic competitors for the first time, the Senate health committee last week voted 16 to 7 to give the name-brand drug companies 12 years of exclusive marketing rights before a copycat biologic drug could go on the market.

As a result, the FDA currently requires that all biologics subject to the PHSA go through the same complete development and approval process as any other new biologic medicines, and this keeps costs high.

(For more information about the history of the US biologic warfare program and Fort Detrick, go to the following websites: www.detrick.army.mil/cutting_edge/index.cfm, www7.nationalacademies.org/archives/cbw.html, and www.bordeninstitute.army.mil/published.html).html

Another reason why subcutaneous or intramuscular formulation might be associated with an increase in DOSFREQ or higher doses is that biologics given intramuscular or subcutaneously will have go through layers of skin or muscle tissues, and in the process they may be rendered ineffective or fail to reach the desired target sites.

Although there is still a long way to go, anti-CD73 therapy, through the development of CD73 mAb, could constitute a new biologic therapy for treating patients with cancer.

By getting inside the cell and getting the body to produce intracellular proteins, we can go after diseases that today aren't druggable with small molecule drugs or biologics.